Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
Harvard Business School
Teva
Fuji
QuintilesIMS
Colorcon
Argus Health
Cerilliant

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,266,331

« Back to Dashboard

Summary for Patent: 5,266,331
Title: Controlled release oxycodone compositions
Abstract:A solid controlled release, oral dosage form, the dosage form comprising a therapeutically effective amount of oxycodone or a salt thereof in a matrix wherein the dissolution rate in vitro of the dosage form, when measured by the USP Paddle Method of 100 rpm in 900 ml aqueous buffer (pH between 1.6 and 7.2) at 37.degree. C. is between 12.5% and 42.5% (by weight) oxycodone released after 1 hour, between 25% and 55% (by weight) oxycodone released after 2 hours, between 45% and 75% (by weight) oxycodone released after 4 hours and between 55% and 85% (by weight) oxycodone released after 6 hours, the in vitro release rate being independent of pH between pH 1.6 and 7.2 and chosen such that the peak plasma level of oxycodone obtained in vivo occurs between 2 and 4 hours after administration of the dosage form.
Inventor(s): Oshlack; Benjamin (New York, NY), Minogue; John J. (Mount Vernon, NY), Chasin; Mark (Manalpan, NJ)
Assignee: Euroceltique, S.A. (LU)
Application Number:07/800,549
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,266,331
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Composition; Process;

Drugs Protected by US Patent 5,266,331

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 5,266,331

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 144418 ➤ Try a Free Trial
Austria 226822 ➤ Try a Free Trial
Austria 261725 ➤ Try a Free Trial
Austria 261726 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
McKesson
AstraZeneca
Cipla
Daiichi Sankyo
Merck
Chinese Patent Office
US Department of Justice
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.